Evidence map›Paper›PMID 36662339›Full record

ReviewHeart failure reviews2023

A conversion CRT strategy combined with AVJA may be a perspective alternative for heart failure patients with persistent atrial fibrillation.

Mengna Chen, Zhiqiang Dong, Yimin Zhang, Jieyun Liu, Junmeng Zhang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Heart failure reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mengna ChenThe First Hospital of Tsinghua University, No. 6, Jiuxianqiao 1st Street, Chaoyang District, Beijing, 100016, China.
Zhiqiang DongKaifeng Central Hospital of Xinxiang Medical University, Kaifeng, China.
Yimin ZhangThe First Hospital of Tsinghua University, No. 6, Jiuxianqiao 1st Street, Chaoyang District, Beijing, 100016, China.
Jieyun LiuKaifeng Central Hospital of Xinxiang Medical University, Kaifeng, China.
Junmeng ZhangThe First Hospital of Tsinghua University, No. 6, Jiuxianqiao 1st Street, Chaoyang District, Beijing, 100016, China. drjmzh@outlook.com.ORCID 0000-0003-4670-0670
Beijing Hua Xin Hospital · CNXinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) combined with persistent atrial fibrillation (AF) often coexist and may promote the pathological conditions of cardiac dysfunction, leading to poor prognosis. Cardiac resynchronization therapy (CRT) combined with atrioventricular junction ablation (AVJA) is a highly effective treatment for HF patients with underlying AF who either have failed or are not suitable for catheter ablation. The CRT-AVJA combination therapy can improve clinical outcomes in HF patients. Currently, clinical CRT methods are categorized into biventricular pacing (BVP) - based and conduction system pacing (CSP) - based methods. These procedures have inherent advantages and disadvantages, in addition to their considerable differences in clinical applications. This article aims to review the clinical progress of AVJA combined with different CRT strategies for treating HF patients with persistent AF and propose that conversion CRT strategy (BVP/CSP-CRT) combined with AVJA may be a perspective alternative. Meanwhile, we generalize that 7 categories of HF patients with persistent AF may need to consider the CRT-AVJA combination therapy.

Indexed as

Atrial FibrillationCardiac Resynchronization TherapyHeart FailureAtrioventricular NodeHumansTreatment OutcomeAtrioventricular junction ablationCardiac resynchronization therapyHis bundle pacingLeft bundle branch pacingPersistent atrial fibrillation

Identifiers

PMID36662339
OpenAlexW4317566694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.